tiprankstipranks
Advertisement

PAYR - ETF AI Analysis

Compare

Top Page

PAYR

Federated Hermes Enhanced Income ETF (PAYR)

Rating:66Neutral
Price Target:
PAYR, the Federated Hermes Enhanced Income ETF, earns a solid overall rating largely because it holds several strong, income-focused companies like Verizon and Medtronic, which combine solid financial performance, attractive valuations, and supportive earnings outlooks. These strengths are partly offset by more mixed names such as British American Tobacco and Enbridge, where earnings volatility, high leverage, and valuation concerns introduce risk. The main risk factor for the fund is its reliance on a concentrated set of income-oriented stocks, some of which face profitability, debt, or sector-specific challenges that could weigh on future returns.
Positive Factors
Strong Recent Performance
The ETF has shown solid gains so far this year and in recent months, indicating positive momentum.
Top Holdings Mostly Performing Well
Most of the largest positions, including major financial, telecom, and energy names, have delivered strong or steady results, helping support the fund’s returns.
Broad Sector Diversification
The fund spreads its investments across several sectors such as financials, consumer defensive, utilities, health care, and energy, which can help reduce the impact of weakness in any single area.
Negative Factors
Moderate Expense Ratio
The fund’s fee level is not especially low for an income-focused ETF, which slightly reduces the net return investors keep.
Heavy U.S. Concentration
With the vast majority of assets in U.S. securities, the ETF offers limited geographic diversification and remains highly tied to the U.S. market.
Some Lagging Health Care Holdings
A few notable health care positions in the top holdings have shown weak performance, which can drag on overall returns if the trend continues.

PAYR vs. SPDR S&P 500 ETF (SPY)

PAYR Summary

The Federated Hermes Enhanced Income ETF (PAYR) is an actively managed fund that focuses on U.S. and a few international companies that pay steady dividends. It doesn’t track a specific index, but instead picks a mix of sectors like financials, utilities, health care, and energy. Well-known holdings include US Bancorp and Verizon. The fund also sells options (covered calls) to try to generate extra income, making it appealing for investors seeking regular cash flow and some growth. A key risk is that the share price and income can still go up and down with the stock market, and the options strategy may limit upside in strong markets.
How much will it cost me?The Federated Hermes Enhanced Income ETF (PAYR) has an expense ratio of 0.40%, meaning you’ll pay $4 per year for every $1,000 invested. This is slightly higher than average because it’s actively managed, with strategies like covered call writing to enhance income and returns. Active management typically involves more research and trading, which increases costs.
What would affect this ETF?PAYR could benefit from stable or rising U.S. dividend-paying stocks, especially in sectors like Health Care, Utilities, and Financials, which are heavily weighted in the fund. However, economic challenges such as rising interest rates or regulatory changes in energy and financial sectors could negatively impact its performance. Additionally, the covered call strategy may limit upside potential during strong market rallies.

PAYR Top 10 Holdings

PAYR leans heavily on steady, income-rich U.S. names, with regional banks like US Bancorp and PNC Financial quietly powering returns as financials rise. Paychex has been another bright spot, adding a growth tilt to the fund’s dividend focus. On the flip side, tobacco giant British American Tobacco and pipeline operator Enbridge have been lagging lately, acting as a bit of a brake on performance, while Medtronic’s mixed health care story adds some volatility. Overall, it’s a U.S.-centric, dividend-first portfolio with a noticeable tilt toward financials and defensives.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Paychex4.14%$2.82M$44.27B-11.60%
77
Outperform
US Bancorp3.89%$2.65M$96.68B28.52%
76
Outperform
Sanofi3.48%$2.37M$110.61B-10.71%
75
Outperform
Verizon3.47%$2.36M$205.45B11.27%
81
Outperform
TotalEnergies SE3.24%$2.21M€172.86B41.68%
78
Outperform
Medtronic3.04%$2.07M$119.49B0.69%
80
Outperform
British American Tobacco2.90%$1.98M$121.51B-3.93%
59
Neutral
Enbridge2.88%$1.97M$110.10B5.19%
69
Neutral
Regions Financial2.70%$1.84M$25.91B13.64%
79
Outperform
Prologis2.67%$1.82M$137.12B26.29%
76
Outperform

PAYR Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
54.67
Positive
100DMA
53.57
Positive
200DMA
51.78
Positive
Market Momentum
MACD
0.44
Negative
RSI
58.52
Neutral
STOCH
68.57
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For PAYR, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 55.80, equal to the 50-day MA of 54.67, and equal to the 200-day MA of 51.78, indicating a bullish trend. The MACD of 0.44 indicates Negative momentum. The RSI at 58.52 is Neutral, neither overbought nor oversold. The STOCH value of 68.57 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for PAYR.

PAYR Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$65.74M0.40%
66
Neutral
$58.03M0.35%
69
Neutral
$29.47M0.45%
69
Neutral
$18.06M0.25%
72
Outperform
$10.91M0.34%
73
Outperform
$7.65M1.01%
74
Outperform
Performance Comparison
Ticker
Company Name
Price
Change
% Change
PAYR
Federated Hermes Enhanced Income ETF
56.15
9.88
21.35%
FDIV
MarketDesk Focused U.S. Dividend ETF
DIVY
Sound Equity Income ETF
VUS
Virtus US Dividend ETF
JHDV
John Hancock U.S. High Dividend ETF
DDDD
YieldMax U.S. Stocks Target Double Distribution ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement